110 related articles for article (PubMed ID: 1412822)
1. Donor-specific transfusion in living-related renal transplants.
Basri N; Nezamuddin N; Aman H; Banqash H; Sharwani N
Transplant Proc; 1992 Oct; 24(5):1746. PubMed ID: 1412822
[No Abstract] [Full Text] [Related]
2. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
3. Cyclosporin monotherapy in pancreaticorenal transplantation.
Ward RG; Gecim E; Bone JM; Bakran A; Sells RA
Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547
[No Abstract] [Full Text] [Related]
4. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
[No Abstract] [Full Text] [Related]
5. Outcome of live-related donor renal transplants in their second decade.
Georgi BA; Cacciarelli TV; Sumrani N; Goldberg K; Hong JH; Sommer BG
Transplant Proc; 1993 Jun; 25(3):2164-5. PubMed ID: 8516853
[No Abstract] [Full Text] [Related]
6. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
[No Abstract] [Full Text] [Related]
7. Short-term cyclosporine conversion in living related donor renal transplantation--preliminary observations.
Rahman M; Wahab MA; Rashid HU; Kibria SG; Rahman S; Khan MF
Transplant Proc; 1992 Oct; 24(5):1696-7. PubMed ID: 1412801
[No Abstract] [Full Text] [Related]
8. Chagas disease and transplantation.
Vazquez MC; Sabbatiello R; Schiavelli R; Maiolo E; Jacob N; Pattin M; Rearte A
Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
[No Abstract] [Full Text] [Related]
9. Five-year experience with a triple drug protocol in renal transplantation.
Pallardó LM; Sánchez J; García J; Puig N; Sánchez P; Górriz JL; Cruz JM
Transplant Proc; 1992 Feb; 24(1):56-7. PubMed ID: 1539342
[No Abstract] [Full Text] [Related]
10. Late acute rejection in renal transplant recipients: response to steroid treatment.
Prieto C; Pulido F; Rodríguez-Paternina E; Algranati C; Bello I; Farias J; G-Millet V
Transplant Proc; 1992 Feb; 24(1):35-6. PubMed ID: 1539312
[No Abstract] [Full Text] [Related]
11. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
Arbelaez M; Mejia G; Henao JE; Garcia A; Arango JL; Velasquez A; Restrepo J; Garcia LF
Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
[No Abstract] [Full Text] [Related]
12. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
[No Abstract] [Full Text] [Related]
13. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
[No Abstract] [Full Text] [Related]
14. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
15. Hepatitis in renal transplant recipients with and without donor-specific blood transfusion.
Morad Z; Suleiman AB; Kong CT
Transplant Proc; 1989 Feb; 21(1 Pt 2):1825-6. PubMed ID: 2652593
[No Abstract] [Full Text] [Related]
16. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
Kong JM; Jeong JH; Kang JK; Seong IG; Kim BC
Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792
[No Abstract] [Full Text] [Related]
17. Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
Beckingham IJ; Dennis MJ; Innes A; Burden RP; Morgan AG; Bishop MC
Transplant Proc; 1993 Apr; 25(2):2100. PubMed ID: 8470283
[No Abstract] [Full Text] [Related]
18. Contribution of acute rejection to renal allograft loss from chronic rejection.
Sumrani N; Cacciarelli TV; Georgi B; Daskalakis P; Miles AM; Goldberg K; Hong JH; Sommer BG
Transplant Proc; 1993 Jun; 25(3):2259-60. PubMed ID: 8516892
[No Abstract] [Full Text] [Related]
19. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children.
Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z
Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630
[No Abstract] [Full Text] [Related]
20. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
